MedTrace Logo

Effect of Curd Cheese on Metabolic Health in Adults

NCT07676838 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-06-30

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the effects of a diet supplemented with curd cheese on anthropometric measurements, glycemia, and lipid profile in overweight adults. Participants aged 40-64 years with a BMI above 25 will be randomly assigned to an intervention group receiving 100 g of curd cheese at breakfast for 8 weeks or to a control group receiving a standard healthy diet without curd cheese. Primary outcomes include changes in fasting blood glucose and HbA1c, while secondary outcomes are changes in body composition, waist circumference, and lipid profile (HDL, LDL, triglycerides, total cholesterol).

Conditions

  • Cholesterol
  • Lipid Profile
  • Diabete Mellitus

Interventions

DIETARY_SUPPLEMENT

Curd Cheese Supplemented Diet

This intervention consists of daily consumption of 100 grams of curd cheese as part of a personalized dietary plan for 8 weeks. Curd cheese is consumed at breakfast and integrated into the participants' regular meal plans. The diet is balanced for total energy and macronutrient distribution according to individual nutritional needs. All participants in this arm receive the same type and brand of curd cheese throughout the intervention period.

Sponsors & Collaborators

  • Halic University

    collaborator OTHER

  • Süleyman Kılıç

    lead OTHER

Principal Investigators

  • Ahmet M GÜNAL, PhD, RD · Haliç University

  • Salim YILMAZ, PhD · Acıbadem Mehmet Ali Aydınlar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-12
Primary Completion
2026-05-22
Completion
2026-06-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07676838 on ClinicalTrials.gov